Related Experiment Videos
Ménière's disease in childhood
1Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama-shi, Okayama 700-8558, Japan. akagih@cc.okayama-u.ac.jp
International Journal of Pediatric Otorhinolaryngology
|November 9, 2001
Summary
Ménière's disease is rare in children, but this study highlights treatment variations. Intratympanic gentamicin sulfate effectively managed severe, persistent vertigo and hearing loss in one pediatric case.
Area of Science:
- Otolaryngology
- Pediatric Neurology
Background:
- Ménière's disease, a disorder of the inner ear, is infrequently diagnosed in pediatric populations.
- Understanding its presentation and treatment efficacy in children is crucial for effective management.
Observation:
- Three rare pediatric cases of Ménière's disease were observed.
- Two cases showed recovery with initial medical therapy.
- One case presented with recurrent vertigo and progressive hearing loss despite medication.
Findings:
- The third case, with persistent vertigo and fluctuating hearing loss, ultimately responded to intratympanic gentamicin sulfate.
- This intervention led to the cessation of definitive vertigo spells.
- The incidence of Ménière's disease among pediatric patients presenting with vertigo at the reporting department was 2.9%.
Implications:
- Intratympanic gentamicin sulfate may be a viable treatment option for severe pediatric Ménière's disease refractory to medical management.
- Further research into pediatric Ménière's disease is warranted to optimize diagnostic and therapeutic strategies.
- Early and accurate diagnosis is essential for managing this rare condition in children.